1. Home
  2. NVO vs CAT Comparison

NVO vs CAT Comparison

Compare NVO & CAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVO
  • CAT
  • Stock Information
  • Founded
  • NVO 1923
  • CAT 1925
  • Country
  • NVO Denmark
  • CAT United States
  • Employees
  • NVO N/A
  • CAT N/A
  • Industry
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • CAT Construction/Ag Equipment/Trucks
  • Sector
  • NVO Health Care
  • CAT Industrials
  • Exchange
  • NVO Nasdaq
  • CAT Nasdaq
  • Market Cap
  • NVO 278.0B
  • CAT 229.8B
  • IPO Year
  • NVO N/A
  • CAT N/A
  • Fundamental
  • Price
  • NVO $59.29
  • CAT $487.55
  • Analyst Decision
  • NVO Buy
  • CAT Buy
  • Analyst Count
  • NVO 9
  • CAT 13
  • Target Price
  • NVO $82.20
  • CAT $465.62
  • AVG Volume (30 Days)
  • NVO 15.4M
  • CAT 3.0M
  • Earning Date
  • NVO 11-05-2025
  • CAT 10-29-2025
  • Dividend Yield
  • NVO 2.08%
  • CAT 1.24%
  • EPS Growth
  • NVO 24.25
  • CAT N/A
  • EPS
  • NVO 3.93
  • CAT 19.66
  • Revenue
  • NVO $49,108,936,497.00
  • CAT $63,139,000,000.00
  • Revenue This Year
  • NVO $9.58
  • CAT N/A
  • Revenue Next Year
  • NVO $7.39
  • CAT $6.30
  • P/E Ratio
  • NVO $15.02
  • CAT $24.76
  • Revenue Growth
  • NVO 20.91
  • CAT N/A
  • 52 Week Low
  • NVO $45.05
  • CAT $267.30
  • 52 Week High
  • NVO $120.56
  • CAT $505.59
  • Technical
  • Relative Strength Index (RSI)
  • NVO 55.41
  • CAT 69.25
  • Support Level
  • NVO $53.77
  • CAT $459.58
  • Resistance Level
  • NVO $60.90
  • CAT $505.59
  • Average True Range (ATR)
  • NVO 1.54
  • CAT 11.25
  • MACD
  • NVO 0.25
  • CAT 1.99
  • Stochastic Oscillator
  • NVO 64.90
  • CAT 67.41

About NVO Novo Nordisk A/S

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About CAT Caterpillar Inc.

Caterpillar is the world's leading manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. Its reporting segments are: construction industries, resource industries, and energy & transportation. Market share approaches 20% across many products. Caterpillar operates a captive finance subsidiary to facilitate sales. The firm has a global reach that is approximately evenly balanced between the US and the rest of the world. Construction skews more domestic, while the other divisions are more geographically diversified. An independent network of over 150 dealers operates approximately 2,800 facilities, giving Caterpillar reach into about 190 countries for sales and support services.

Share on Social Networks: